Inhibition 0f inflammation using antagonists of MUC1

Details for Australian Patent Application No. 2010253834 (hide)

Owner Genus Oncology, LLC Dana-Farber Cancer Institute, Inc.

Inventors Kufe, Donald W.; Kharbanda, Surender

Agent Pizzeys

Pub. Number AU-A-2010253834

PCT Pub. Number WO2010/138740

Priority 61/253,730 21.10.09 US; 61/181,530 27.05.09 US; 61/303,997 12.02.10 US

Filing date 27 May 2010

Wipo publication date 2 December 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/09 (2006.01) Medicinal preparations containing peptides

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

Event Publications

8 December 2011 PCT application entered the National Phase

  PCT publication WO2010/138740 Priority application(s): WO2010/138740

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010253836-Monitoring of redundant conductors

2010253830-A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use